Literature DB >> 31782120

Patient Preferences in the Medical Product Lifecycle.

Jennifer A Whitty1,2, Esther W de Bekker-Grob3,4, Nigel S Cook5, Fern Terris-Prestholt6, Michael Drummond7, Rocco Falchetto8, Hans L Hillege9.   

Abstract

Entities:  

Year:  2020        PMID： 31782120     DOI： 10.1007/s40271-019-00400-y

Source DB:  PubMed          Journal:  Patient        ISSN： 1178-1653            Impact factor:   3.883


× No keyword cloud information.
  17 in total

1.  Support Tools for Preference-Sensitive Decisions in Healthcare: Where Are We? Where Do We Go? How Do We Get There?

Authors:  Jan Ostermann; Derek S Brown; Janine A van Til; Nick Bansback; France Légaré; Deborah A Marshall; Meenakshi Bewtra
Journal:  Patient       Date:  2019-10       Impact factor: 3.883

2.  Issues in the Design of Discrete Choice Experiments.

Authors:  Richard Norman; Benjamin M Craig; Paul Hansen; Marcel F Jonker; John Rose; Deborah J Street; Brendan Mulhern
Journal:  Patient       Date:  2019-06       Impact factor: 3.883

3.  Symposium Title: Preference Evidence for Regulatory Decisions.

Authors:  Juan Marcos Gonzalez; F Reed Johnson; Bennett Levitan; Rebecca Noel; Holly Peay
Journal:  Patient       Date:  2018-10       Impact factor: 3.883

4.  Patient Engagement at a Tipping Point-The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, "Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products".

Authors:  Meredith Y Smith; Tarek A Hammad; Marilyn Metcalf; Bennett Levitan; Rebecca Noel; Anne M Wolka; Debra L Michaels; F Reed Johnson
Journal:  Ther Innov Regul Sci       Date:  2016-09       Impact factor: 1.778

5.  Advancing the Use of Patient Preference Information as Scientific Evidence in Medical Product Evaluation: A Summary Report of the Patient Preference Workshop.

Authors:  Heather L Benz; Ting-Hsuan Joyce Lee; Jui-Hua Tsai; John F P Bridges; Sara Eggers; Megan Moncur; Fadia T Shaya; Ira Shoulson; Erica S Spatz; Leslie Wilson; Anindita Saha
Journal:  Patient       Date:  2019-12       Impact factor: 3.883

6.  Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations.

Authors:  Joanna Coast; Hareth Al-Janabi; Eileen J Sutton; Susan A Horrocks; A Jane Vosper; Dawn R Swancutt; Terry N Flynn
Journal:  Health Econ       Date:  2011-05-06       Impact factor: 3.046

7.  Patients' perspectives can be integrated in health technology assessments: an exploratory analysis of CADTH Common Drug Review.

Authors:  Sarah Berglas; Lauren Jutai; Gail MacKean; Laura Weeks
Journal:  Res Involv Engagem       Date:  2016-06-07

8.  Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs.

Authors:  Nigel S Cook; Julie Cave; Anke-Peggy Holtorf
Journal:  Front Med (Lausanne)       Date:  2019-04-24

9.  Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA.

Authors:  Rosanne Janssens; Selena Russo; Eline van Overbeeke; Chiara Whichello; Sarah Harding; Jürgen Kübler; Juhaeri Juhaeri; Karin Schölin Bywall; Alina Comanescu; Axel Hueber; Matthias Englbrecht; Nikoletta Nikolenko; Gabriella Pravettoni; Steven Simoens; Hilde Stevens; Richard Hermann; Bennett Levitan; Irina Cleemput; Esther de Bekker-Grob; Jorien Veldwijk; Isabelle Huys
Journal:  Patient       Date:  2019-10       Impact factor: 3.883

10.  Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI's Patient Groups and Clinical Trials Project.

Authors:  Bennett Levitan; Kenneth Getz; Eric L Eisenstein; Michelle Goldberg; Matthew Harker; Sharon Hesterlee; Bray Patrick-Lake; Jamie N Roberts; Joseph DiMasi
Journal:  Ther Innov Regul Sci       Date:  2017-07-17       Impact factor: 1.778
View more
  3 in total

1.  Can We Afford to Exclude Patients Throughout Health Technology Assessment?

Authors:  Janet L Wale; David Chandler; Deborah Collyar; Dominique Hamerlijnck; Roberto Saldana; Zack Pemberton-Whitely
Journal:  Front Med Technol       Date:  2022-01-25

2.  The Patient Perspective: A Matter of Minutes.

Authors:  Rocco Falchetto
Journal:  Patient       Date:  2020-02       Impact factor: 3.883

Review 3.  The Use of Patient-Reported Outcome Measures in Rare Diseases and Implications for Health Technology Assessment.

Authors:  Amanda Whittal; Michela Meregaglia; Elena Nicod
Journal:  Patient       Date:  2021-01-19       Impact factor: 3.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.